0001717590-18-000001.txt : 20180628 0001717590-18-000001.hdr.sgml : 20180628 20180628161037 ACCESSION NUMBER: 0001717590-18-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180626 FILED AS OF DATE: 20180628 DATE AS OF CHANGE: 20180628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Keefer Jason CENTRAL INDEX KEY: 0001717590 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32966 FILM NUMBER: 18925465 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSIRIS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001360886 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 710881115 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 443-545-1819 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-06-26 0 0001360886 OSIRIS THERAPEUTICS, INC. OSIR 0001717590 Keefer Jason 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 0 1 0 0 Interim President and CEO Incentive Stock Option (right to buy) 10.53 2018-06-26 4 A 0 20000 0 A 2019-06-26 2028-06-26 Common Stock 20000 36000 D 25% of the shares underlying this option shall vest on each of June 26, 2019, June 26, 2020, June 26, 2021 and June 26, 2022, subject to Reporting Person's continued service through the applicable vesting date. Jason Keefer 2018-06-28